中国P站

Influenza; Airborne transmission; Aerosols; Viral shedding; Relative humidity; Ventilation; Masks; Ferret model; Infectivity; Public health

Introduction

This systematic review compiles evidence on influenza viral shedding in exhaled particles and aerosols from infected patients. It highlights that influenza virus can be detected in both coarse and fine aerosols, indicating potential for airborne transmission. The findings emphasize the variability in shedding across individuals and disease stages, underscoring the complexity of defining the risk posed by aerosolized virus. This data is crucial for understanding how influenza spreads through the air, informing public health interventions, and improving models of transmission dynamics.[1] This study investigated the presence of influenza virus RNA in aerosols generated by coughing. It confirmed that individuals infected with influenza release viral RNA into the air through coughs, even in the absence of severe symptoms. The research emphasizes the potential for airborne transmission through respiratory activities, highlighting the importance of understanding aerosol dynamics in disease spread. This work provides direct evidence of influenza virus components in exhaled air, supporting the role of aerosols in person-to-person transmission.[2] This study uses ferrets, a common model for influenza, to demonstrate that both symptomatic and asymptomatic animals can generate infectious airborne influenza virus. The findings suggest that asymptomatic carriers may play a significant role in airborne transmission, complicating control efforts. Understanding that even mild or unapparent infections can contribute to aerosolized virus spread is vital for developing comprehensive public health strategies, including improved surveillance and broader mitigation measures.[3] This study explores the crucial role of relative humidity (RH) in the inactivation of airborne influenza virus. It identifies that intermediate RH levels (e.g., 40-60%) are often optimal for viral survival in aerosols, while very low or very high RH can lead to faster inactivation. Understanding how environmental conditions like humidity affect the viability of airborne influenza is essential for designing effective public health interventions and controlling indoor transmission, particularly during seasonal outbreaks.[4] This study investigated the role of ventilation in mitigating airborne influenza transmission within healthcare settings. It concluded that improved ventilation strategies, such as increased air changes per hour, significantly reduce the concentration of airborne viral particles, thereby lowering the risk of transmission. The findings emphasize that engineering controls are critical for protecting healthcare workers and patients from airborne pathogens, reinforcing the importance of proper building design and maintenance in infection control.[5] This research investigated the correlation between viral load in exhaled breath aerosols and the infectiousness of influenza. It revealed that higher viral loads in aerosols are associated with increased infectivity, directly linking the amount of airborne virus to transmission risk. The study provides critical insights into the dynamics of influenza shedding and offers a potential biomarker for assessing an individual's contagiousness through airborne routes, which is vital for targeted intervention strategies.[6] This systematic review and meta-analysis assessed the effectiveness of masks in preventing airborne influenza transmission. The findings indicate that masks, particularly surgical masks, can significantly reduce the emission of infectious respiratory droplets and aerosols, thereby decreasing the risk of airborne spread. The research underscores the importance of mask-wearing as a non-pharmaceutical intervention in public health strategies to control influenza and other respiratory viral diseases transmitted via the air.[7] This study examined how relative humidity and temperature influence the survival of airborne influenza virus. It demonstrated that both factors significantly impact viral viability in aerosols, with specific ranges of humidity and temperature optimizing or hindering survival. These findings are crucial for understanding the seasonality of influenza and for modeling transmission risks in various indoor and outdoor environments. Effective control strategies should consider these environmental variables to minimize airborne spread.[8] This study employed a ferret model to investigate the airborne transmission of a pandemic-potential influenza A virus. It effectively demonstrated robust airborne transmission between ferrets, confirming the high efficiency of this route for certain influenza strains. The research highlights the critical need for continued surveillance of emerging influenza viruses and underscores the importance of understanding their airborne transmission potential to predict and prepare for future pandemics.[9] This narrative review synthesizes current understanding of airborne influenza transmission and the effectiveness of personal protective equipment (PPE), specifically masks and respirators. It highlights the growing evidence supporting the airborne route for influenza and reinforces that proper use of PPE is critical for reducing exposure. The review emphasizes the importance of a multi-faceted approach, combining environmental controls with personal protection, to effectively mitigate the spread of influenza through the air.[10]

Description

Understanding influenza transmission dynamics is crucial for effective public health interventions. Recent systematic reviews confirm that influenza virus sheds in exhaled particles and aerosols from infected patients, with detection possible in both coarse and fine aerosols, indicating significant potential for airborne transmission. This shedding varies across individuals and disease stages, adding complexity to assessing aerosolized virus risk [1]. Complementing this, direct studies have identified influenza virus RNA in aerosols generated by coughing, even from individuals without severe symptoms, reinforcing the idea that respiratory activities, including mild ones, contribute to airborne spread. This provides robust evidence for influenza virus components in exhaled air, supporting its role in person-to-person transmission via aerosols [2].

Further research using animal models, specifically ferrets, provides critical insights into the infectious nature of airborne influenza. Ferret studies demonstrate that both symptomatic and asymptomatic animals can generate infectious airborne influenza virus. This implies that asymptomatic carriers could play a substantial role in airborne transmission, complicating disease control efforts significantly. Recognizing that even mild or unapparent infections can contribute to aerosolized virus spread is essential for developing comprehensive public health strategies, including enhanced surveillance and broader mitigation measures [3]. Moreover, ferret models have been instrumental in investigating the airborne transmission of pandemic-potential influenza A viruses, confirming the high efficiency of this route for specific strains. Such findings highlight the critical need for continuous surveillance of emerging influenza viruses and a deep understanding of their airborne transmission potential to predict and prepare for future pandemics effectively [9].

Environmental factors are pivotal in determining the viability and spread of airborne influenza. Studies reveal the crucial role of relative humidity (RH) in the inactivation of airborne influenza virus. Intermediate RH levels, typically between 40-60%, are often identified as optimal for viral survival in aerosols, whereas very low or very high RH can lead to faster inactivation. Understanding how conditions like humidity affect airborne influenza viability is fundamental for designing effective public health interventions and controlling indoor transmission, especially during seasonal outbreaks [4]. This environmental influence extends to temperature as well. Research demonstrates that both relative humidity and temperature significantly impact viral viability in aerosols, with specific ranges optimizing or hindering survival. These findings are key to understanding the seasonality of influenza and for modeling transmission risks in diverse environments. Integrating these environmental variables into control strategies is essential to minimize airborne spread [8]. Beyond survival, the viral load in exhaled breath aerosols directly correlates with the infectiousness of influenza, indicating that higher viral loads are associated with increased transmission risk. This provides critical insights into influenza shedding dynamics and offers a potential biomarker for assessing an individual's contagiousness through airborne routes, guiding targeted intervention strategies [6].

Given the evidence for airborne transmission, mitigation strategies are paramount. Improved ventilation strategies, such as increasing air changes per hour, have been shown to significantly reduce the concentration of airborne viral particles, thereby lowering the risk of transmission within healthcare settings. These findings underscore that engineering controls are vital for protecting healthcare workers and patients from airborne pathogens, emphasizing proper building design and maintenance in infection control [5].

Additionally, the effectiveness of personal protective equipment (PPE) has been extensively reviewed. Systematic reviews and meta-analyses indicate that masks, particularly surgical masks, can significantly reduce the emission of infectious respiratory droplets and aerosols, decreasing airborne spread. This reinforces mask-wearing as a critical non-pharmaceutical intervention in public health strategies for influenza and other respiratory viral diseases [7]. A comprehensive approach, as highlighted by narrative reviews, emphasizes combining environmental controls with personal protection like masks and respirators to effectively mitigate airborne influenza spread. Proper use of PPE is central to reducing exposure in this multi-faceted strategy [10].

Conclusion

Research consistently demonstrates that influenza virus transmits through airborne routes, with viral particles present in both coarse and fine exhaled aerosols from infected patients [1]. Even individuals without severe symptoms, or those only coughing, release influenza viral RNA into the air, underscoring the pervasive nature of aerosol transmission [2]. Animal models, particularly ferrets, further confirm that both symptomatic and asymptomatic subjects can generate infectious airborne influenza virus, implying that symptom-free carriers significantly contribute to spread [3, 9]. A direct correlation exists between higher viral loads in exhaled breath aerosols and increased infectivity, offering insights into an individual's contagiousness [6]. Environmental conditions such as relative humidity and temperature critically influence viral survival; intermediate humidity levels (e.g., 40-60%) are often optimal for maintaining viral viability in aerosols, while very low or high humidity and certain temperatures can lead to faster inactivation [4, 8]. Mitigation efforts are vital, with improved ventilation strategies substantially reducing airborne viral particle concentrations in healthcare environments [5]. Moreover, the proper use of personal protective equipment, especially masks, effectively reduces the emission of infectious respiratory droplets and aerosols, reinforcing their role in public health interventions [7, 10]. This body of work underscores the complexity of influenza transmission, offering crucial data for refining public health strategies, improving transmission models, and enhancing pandemic preparedness.

References

1. Laura EPLH, Natalie ED, David LS (2023) .Influenza Other Respir Viruses 17:e13175.

   , ,

2. N. MVD, T. JVvR, B. LMvG (2020) .J Gen Virol 101:310-313.

   , ,

3. M. R, A. REdG, M. CGHvdV (2021) .Sci Rep 11:3822.

   , ,

4. Linsey CM, Elia CPDG, Megan CDG (2019) .Aerosol Sci Technol 53:1251-1262.

   , ,

5. N. HLL, M. C, S. LC (2020) .Infect Control Hosp Epidemiol 41:676-681.

   , ,

6. P. Y, R. Z, X. ZH (2022) .Clin Infect Dis 75:e156-e160.

   , ,

7. M. DEW, E. VL, N. HLL (2020) .Infect Control Hosp Epidemiol 41:849-856.

   , ,

8. N. HLL, K. CQL, S. LC (2021) .J Med Virol 93:1157-1165.

   , ,

9. J. CRDK, J. HP, H. JL (2023) .Viruses 15:1682.

   , ,

10. K. CQL, N. HLL, B. JC (2020) .Viruses 12:956.

    , ,